Primary human testicular PDGFRα+ cells are multipotent and can be differentiated into cells with Leydig cell characteristics in vitro.
Aged
Animals
Cell Culture Techniques
/ methods
Cell Differentiation
/ genetics
Cells, Cultured
Culture Media
Heterografts
Humans
Leydig Cells
/ metabolism
Male
Mice
Mice, Knockout
Middle Aged
Multipotent Stem Cells
/ metabolism
Prostatic Neoplasms
/ pathology
Receptor, Platelet-Derived Growth Factor alpha
/ metabolism
Receptors, LH
/ genetics
Spermatogenesis
/ genetics
Testosterone
/ blood
PDGFRα
mesenchymal stromal cell
stem Leydig cell
steroidogenesis
testis
Journal
Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199
Informations de publication
Date de publication:
29 09 2019
29 09 2019
Historique:
received:
19
12
2018
revised:
22
05
2019
pubmed:
10
8
2019
medline:
10
9
2020
entrez:
10
8
2019
Statut:
ppublish
Résumé
Is it possible to differentiate primary human testicular platelet-derived growth factor receptor alpha positive (PDGFRα+) cells into functional Leydig cells? Although human testicular PDGFRα+ cells are multipotent and are capable of differentiating into steroidogenic cells with Leydig cell characteristics, they are not able to produce testosterone after differentiation. In rodents, stem Leydig cells (SLCs) that have been identified and isolated using the marker PDGFRα can give rise to adult testosterone-producing Leydig cells after appropriate differentiation in vitro. Although PDGFRα+ cells have also been identified in human testicular tissue, so far there is no evidence that these cells are true human SLCs that can differentiate into functional Leydig cells in vitro or in vivo. We isolated testicular cells enriched for interstitial cells from frozen-thawed fragments of testicular tissue from four human donors. Depending on the obtained cell number, PDGFRα+-sorted cells of three to four donors were exposed to differentiation conditions in vitro to stimulate development into adipocytes, osteocytes, chondrocytes or into Leydig cells. We compared their cell characteristics with cells directly after sorting and cells in propagation conditions. To investigate their differentiation potential in vivo, PDGFRα+-sorted cells were transplanted in the testis of 12 luteinizing hormone receptor-knockout (LuRKO) mice of which 6 mice received immunosuppression treatment. An additional six mice did not receive cell transplantation and were used as a control. Human testicular interstitial cells were cultured to Passage 3 and FACS sorted for HLA-A,B,C+/CD34-/PDGFRα+. We examined their mesenchymal stromal cell (MSC) membrane protein expression by FACS analyses. Furthermore, we investigated lineage-specific staining and gene expression after MSC trilineage differentiation. For the differentiation into Leydig cells, PDGFRα+-sorted cells were cultured in either proliferation or differentiation medium for 28 days, after which they were stimulated either with or without hCG, forskolin or dbcAMP for 24 h to examine the increase in gene expression of steroidogenic enzymes using qPCR. In addition, testosterone, androstenedione and progesterone levels were measured in the culture medium. We also transplanted human PDGFRα+-sorted testicular interstitial cells into the testis of LuRKO mice. Serum was collected at several time points after transplantation, and testosterone was measured. Twenty weeks after transplantation testes were collected for histological examination. From primary cultured human testicular interstitial cells at Passage 3, we could obtain a population of HLA-A,B,C+/CD34-/PDGFRα+ cells by FACS. The sorted cells showed characteristics of MSC and were able to differentiate into adipocytes, chondrocytes and osteocytes. Upon directed differentiation into Leydig cells in vitro, we observed a significant increase in the expression of HSD3B2 and INSL3. After 24 h stimulation with forskolin or dbcAMP, a significantly increased expression of STAR and CYP11A1 was observed. The cells already expressed HSD17B3 and CYP17A1 before differentiation but the expression of these genes were not significantly increased after differentiation and stimulation. Testosterone levels could not be detected in the medium in any of the stimulation conditions, but after stimulation with forskolin or dbcAMP, androstenedione and progesterone were detected in culture medium. After transplantation of the human cells into the testes of LuRKO mice, no significant increase in serum testosterone levels was found compared to the controls. Also, no human cells were identified in the interstitium of mice testes 20 weeks after transplantation. N/A. This study was performed using tissue from only four donors because of limitations in donor material. Because of the need of sufficient cell numbers, we first propagated cells to passage 3 before FACS of the desired cell population was performed. We cannot rule out this propagation of the cells resulted in loss of stem cell properties. A lot of information on Leydig cell development is obtained from rodent studies, while the knowledge on human Leydig cell development is very limited. Our study shows that human testicular interstitial PDGFRα+ cells have different characteristics compared to rodent testicular PDGFRα+ cells in gene expression levels of steroidogenic enzymes and potential to differentiate in adult Leydig cells under comparable culture conditions. This emphasizes the need for confirming results from rodent studies in the human situation to be able to translate this knowledge to the human conditions, to eventually contribute to improvements of testosterone replacement therapies or establishing alternative cell therapies in the future, potentially based on SLCs. This study was funded by Amsterdam UMC, location AMC, Amsterdam, the Netherlands. All authors declare no competing interests.
Identifiants
pubmed: 31398257
pii: 5544643
doi: 10.1093/humrep/dez131
pmc: PMC6735802
doi:
Substances chimiques
Culture Media
0
Receptors, LH
0
Testosterone
3XMK78S47O
Receptor, Platelet-Derived Growth Factor alpha
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1621-1631Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
Références
Endocrinology. 2000 Jul;141(7):2631-7
pubmed: 10875268
Mol Endocrinol. 2001 Jan;15(1):172-83
pubmed: 11145748
J Endocrinol. 2001 Feb;168(2):213-6
pubmed: 11182757
Mol Cell Endocrinol. 2001 Jun 20;179(1-2):47-74
pubmed: 11420130
Genes Dev. 2003 Mar 15;17(6):800-10
pubmed: 12651897
Biol Reprod. 2004 Jan;70(1):32-8
pubmed: 12954730
Int Rev Cytol. 2004;233:181-241
pubmed: 15037365
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2719-24
pubmed: 16467141
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Ann N Y Acad Sci. 2007 Dec;1120:16-35
pubmed: 18184909
Nucleic Acids Res. 2009 Apr;37(6):e45
pubmed: 19237396
Biochem Biophys Res Commun. 2009 Aug 7;385(4):570-5
pubmed: 19482010
Ther Clin Risk Manag. 2009 Jun;5(3):427-48
pubmed: 19707253
JAMA. 2009 Nov 18;302(19):2127-34
pubmed: 19920237
Int J Dev Biol. 2010;54(5):779-86
pubmed: 20446275
Endocrinology. 2012 Oct;153(10):5002-10
pubmed: 22865373
Mol Endocrinol. 2013 Jan;27(1):63-73
pubmed: 23125070
Mol Cell Endocrinol. 2013 Jun 15;372(1-2):96-104
pubmed: 23545158
BMC Med. 2013 Apr 18;11:108
pubmed: 23597181
Mol Hum Reprod. 2014 Feb;20(2):155-67
pubmed: 24214658
Eur J Microbiol Immunol (Bp). 2012 Jun;2(2):112-20
pubmed: 24672679
J Clin Endocrinol Metab. 2014 Jul;99(7):E1227-35
pubmed: 24684461
Hum Reprod Update. 2015 May-Jun;21(3):310-28
pubmed: 25724971
Clin Chim Acta. 2016 May 1;456:15-18
pubmed: 26920638
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2666-71
pubmed: 26929346
Stem Cells Int. 2017;2017:2740272
pubmed: 28243257
J Androl. 1988 Sep-Oct;9(5):343-51
pubmed: 2853150
Front Physiol. 2017 Jun 28;8:430
pubmed: 28701961
Cell Death Dis. 2017 Oct 12;8(10):e3123
pubmed: 29022899
Endocrinology. 1989 Feb;124(2):762-70
pubmed: 2912699
J Reprod Fertil. 1986 Jan;76(1):1-10
pubmed: 3003355
Cell Tissue Res. 1985;242(1):145-56
pubmed: 4042133
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):61-8
pubmed: 7626518
Biol Reprod. 1996 Aug;55(2):439-44
pubmed: 8828852